Skip to main content

Quest Diagnostics income statement

  • DGX · NYSE
  • Healthcare
  • Health Care Services
  • S&P 500
$259.60−0.02%Close 13 Nov 2026 · Market value $28.70B

Quest Diagnostics reported revenue of $11.0 billion for fiscal year 2025 (the twelve months to 31 Dec 2025), up 11.8% from fiscal 2024. Net income was $992 million and diluted earnings per share $8.75.

From Quest Diagnostics's annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 31 Dec 2025. TTM is the last four reported quarters added up.

Annual

Quest Diagnostics income statement, annual
USDFY 2007FY 2008FY 2009FY 2010FY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Revenue$6.70B$7.25B$7.46B$7.26B$7.39B$7.38B$7.15B$7.43B$7.49B$7.21B$7.40B$7.53B$7.73B$9.44B$10.79B$9.88B$9.25B$9.87B$11.04B$11.84B
Revenue growth—+8.1%+2.8%−2.6%+1.8%−0.1%−3.2%+4.0%+0.8%−3.7%+2.6%+1.7%+2.6%+22.1%+14.3%−8.4%−6.4%+6.7%+11.8%—
Net interest income——————−$159.0M−$164.0M−$153.0M−$143.0M−$151.0M−$167.0M−$175.0M−$163.0M−$151.0M−$138.0M−$152.0M−$201.0M−$264.0M−$251.0M
Cost of revenue$3.97B$4.26B$4.32B$4.28B$4.36B$4.37B$4.33B$4.64B$4.66B$4.62B$4.72B$4.93B$5.04B$5.80B$6.58B$6.45B$6.20B$6.63B$7.37B$7.92B
Gross profit$2.74B$2.99B$3.13B$3.05B$3.03B$3.02B$2.82B$2.80B$2.84B$2.60B$2.68B$2.60B$2.69B$3.63B$4.21B$3.43B$3.05B$3.24B$3.67B$3.92B
Gross margin40.8%41.3%42.0%42.0%41.0%40.9%39.5%37.6%37.8%36.0%36.2%34.6%34.8%38.5%39.0%34.7%33.0%32.9%33.2%33.1%
Selling, general and administrative$1.61B$1.74B$1.75B$1.66B$1.74B$1.75B$1.70B$1.73B$1.68B$1.38B$1.44B$1.42B$1.46B$1.55B$1.73B$1.87B$1.64B$1.77B$1.97B$2.06B
Operating expenses$1.64B$1.77B$1.77B—————————$1.46B———————
Operating income$1.09B$1.22B$1.36B$1.28B$987.0M$1.20B$1.48B$983.0M$1.40B$1.28B$1.17B$1.10B$1.23B$1.97B$2.38B$1.43B$1.26B$1.35B$1.56B$1.72B
Operating margin16.3%16.9%18.2%17.7%13.4%16.3%20.6%13.2%18.7%17.7%15.7%14.6%15.9%20.9%22.1%14.4%13.6%13.6%14.1%14.6%
Interest expense—$185.5M$146.6M$147.5M$173.3M——$167.0M$154.0M$144.0M$153.0M$169.0M$180.0M$166.0M$152.0M$148.0M$163.0M$226.0M$277.0M$267.0M
Other income and expense−$152.4M−$171.7M−$131.2M−$108.6M−$138.0M−$133.0M−$151.0M−$160.0M−$296.0M−$191.0M−$135.0M−$175.0M−$155.0M−$87.00M$218.0M−$193.0M−$132.0M−$171.0M−$238.0M−$231.0M
Income before tax—$1.05B$1.23B$1.18B$856.2M—$1.32B$823.0M$1.10B$1.09B$1.03B$926.0M$1.08B$1.88B$2.60B$1.24B$1.13B$1.18B$1.32B$1.49B
Income tax expense$358.6M$386.8M$460.5M$430.1M$355.0M$402.0M$500.0M$262.0M$373.0M$429.0M$241.0M$182.0M$247.0M$460.0M$597.0M$264.0M$248.0M$273.0M$314.0M$342.0M
Effective tax rate—36.8%37.5%36.3%41.5%—37.8%31.8%33.8%39.5%23.4%19.7%23.0%24.4%23.0%21.4%21.9%23.2%23.8%22.9%
Net income$339.9M$581.5M$729.1M$720.9M$471.0M$556.0M$849.0M$556.0M$709.0M$645.0M$772.0M$736.0M$858.0M$1.43B$2.00B$946.0M$854.0M$871.0M$992.0M$1.13B
Net margin5.1%8.0%9.8%9.9%6.4%7.5%11.9%7.5%9.5%8.9%10.4%9.8%11.1%15.2%18.5%9.6%9.2%8.8%9.0%9.5%
Net income to common shareholders———————$549.0M$706.0M$642.0M$769.0M—————————
EPS · diluted$1.74$2.96$3.87$4.05$2.92$3.46$5.54$3.81$4.87$4.51$5.50$5.29$6.28$10.47$15.55$7.97$7.49$7.69$8.75$10.03
Diluted weighted average shares195M196M188M177M160M160M153M145M145M142M140M139M136M136M128M118M113M113M113M113M
Basic weighted average shares—194M186M176M159M159M152M145M144M140M137M136M134M134M125M116M112M111M111M110M
EBITDA$1.33B$1.49B$1.62B$1.54B$1.27B$1.49B$1.76B$1.30B$1.70B$1.53B$1.44B$1.41B$1.56B$2.33B$2.79B$1.86B$1.70B$1.84B$2.13B$2.31B
EBITDA margin19.8%20.5%21.7%21.2%17.2%20.2%24.6%17.4%22.7%21.2%19.4%18.7%20.2%24.7%25.9%18.9%18.4%18.6%19.3%19.5%
Depreciation & amortization$237.9M$264.6M$256.7M$254.0M$281.0M$287.0M$283.0M$314.0M$304.0M$249.0M$270.0M$309.0M$329.0M$361.0M$408.0M$437.0M$439.0M$493.0M$570.0M$585.0M
Stock-based compensation$56.85M$70.58M$75.06M$53.93M$72.00M$50.00M$28.00M$51.00M$52.00M$69.00M$79.00M$61.00M$56.00M$97.00M$79.00M$77.00M$77.00M$88.00M$88.00M$88.00M
Dividends per share$0.40$0.40$0.40$0.40$0.47$0.81$1.20$1.32$1.52$1.65$1.80—————————

Quarterly

Quest Diagnostics income statement, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Revenue$2.29B$2.37B$2.40B$2.49B$2.62B$2.65B$2.76B$2.82B$2.81B$2.90B$3.04B$3.10B
Net interest income−$40.00M−$43.00M−$44.00M−$49.00M−$65.00M−$67.00M−$67.00M−$66.00M−$64.00M−$63.00M−$63.00M−$61.00M
Cost of revenue$1.55B$1.59B$1.59B$1.68B$1.76B$1.79B$1.82B$1.87B$1.90B$1.95B$2.02B$2.06B
Gross profit$736.0M$771.0M$804.0M$811.0M$858.0M$863.0M$943.0M$949.0M$910.0M$942.0M$1.03B$1.04B
Gross margin32.2%32.6%33.5%32.6%32.7%32.5%34.2%33.7%32.4%32.5%33.7%33.6%
Selling, general and administrative$407.0M$440.0M$416.0M$448.0M$466.0M$476.0M$486.0M$501.0M$504.0M$504.0M$529.0M$523.0M
Operating income$267.0M$300.0M$355.0M$330.0M$361.0M$346.0M$438.0M$386.0M$386.0M$399.0M$459.0M$479.0M
Operating margin11.7%12.7%14.8%13.3%13.8%13.0%15.9%13.7%13.8%13.8%15.1%15.5%
Interest expense$46.00M$49.00M$47.00M$58.00M$72.00M$72.00M$69.00M$69.00M$67.00M$65.00M$68.00M$67.00M
Other income and expense−$30.00M−$34.00M−$41.00M−$34.00M−$62.00M−$70.00M−$54.00M−$58.00M−$56.00M−$65.00M−$47.00M−$63.00M
Income before tax$237.0M$266.0M$314.0M$296.0M$299.0M$276.0M$384.0M$328.0M$330.0M$334.0M$412.0M$416.0M
Income tax expense$40.00M$66.00M$74.00M$65.00M$68.00M$59.00M$97.00M$77.00M$81.00M$74.00M$88.00M$99.00M
Effective tax rate16.9%24.8%23.6%22.0%22.7%21.4%25.3%23.5%24.5%22.2%21.4%23.8%
Net income$192.0M$194.0M$229.0M$226.0M$222.0M$220.0M$282.0M$245.0M$245.0M$252.0M$320.0M$312.0M
Net margin8.4%8.2%9.6%9.1%8.5%8.3%10.2%8.7%8.7%8.7%10.5%10.1%
Net income to common shareholders—$193.0M$228.0M$225.0M—$219.0M$281.0M——$251.0M$319.0M—
EPS · diluted$1.71$1.72$2.03$1.99$1.92$1.94$2.47$2.16$2.15$2.24$2.84$2.78
Diluted weighted average shares112M112M112M113M115M113M113M113M114M112M112M112M
Basic weighted average shares112M111M111M112M111M111M112M112M108M110M111M110M
EBITDA$376.0M$416.0M$472.0M$455.0M$496.0M$486.0M$581.0M$528.0M$531.0M$546.0M$605.0M$626.0M
EBITDA margin16.4%17.6%19.7%18.3%18.9%18.3%21.0%18.8%18.9%18.9%19.9%20.2%
Depreciation & amortization$109.0M$116.0M$117.0M$125.0M$135.0M$140.0M$143.0M$142.0M$145.0M$147.0M$146.0M$147.0M
Stock-based compensation$19.00M$22.00M$20.00M$19.00M$27.00M$22.00M$21.00M$20.00M$25.00M$20.00M$23.00M$20.00M
Dividends per share—$0.75$0.75$0.75—$0.80$0.80$0.80—$0.86$0.86$0.86

The main figures as JSON and plain text. See data and methodology.

DGX in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.